{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T02:10:18Z","timestamp":1780107018298,"version":"3.54.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T00:00:00Z","timestamp":1343779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Parkinsonism &amp; Related Disorders"],"published-print":{"date-parts":[[2012,8]]},"DOI":"10.1016\/j.parkreldis.2012.04.024","type":"journal-article","created":{"date-parts":[[2012,5,16]],"date-time":"2012-05-16T12:58:13Z","timestamp":1337173093000},"page":"876-880","source":"Crossref","is-referenced-by-count":50,"title":["Gaba and serotonin molecular neuroimaging in essential tremor: A clinical correlation study"],"prefix":"10.1016","volume":"18","author":[{"given":"A.","family":"Gironell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.P.","family":"Figueiras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Pagonabarraga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.R.","family":"Herance","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Pascual-Sedano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Trampal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.D.","family":"Gispert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.parkreldis.2012.04.024_bib1","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/S1474-4422(05)00991-9","article-title":"Essential tremor","volume":"4","author":"Louis","year":"2005","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.parkreldis.2012.04.024_bib2","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/S1474-4422(10)70322-7","article-title":"Treatment of patients with essential tremor","volume":"10","author":"Deuschl","year":"2011","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.parkreldis.2012.04.024_bib3","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1001\/archneur.56.7.807","article-title":"A\u00a0new twist for stopping the shakes? Revisiting GABAergic therapy for essential tremor","volume":"56","author":"Louis","year":"1999","journal-title":"Arch Neurol"},{"key":"10.1016\/j.parkreldis.2012.04.024_bib4","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.2967\/jnumed.109.074120","article-title":"GABAergic dysfunction in essential tremor: an 11C-Flumazenil PET study","volume":"51","author":"Boecker","year":"2010","journal-title":"J\u00a0Nucl Med"},{"key":"10.1016\/j.parkreldis.2012.04.024_bib5","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1097\/00002826-198904000-00009","article-title":"Trazadone in essential tremor. Probe of serotoninergic mechanisms","volume":"12","author":"Koller","year":"1989","journal-title":"Clin Neuropharmacol"},{"key":"10.1016\/j.parkreldis.2012.04.024_bib6","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.bbr.2003.10.035","article-title":"Citalopram, a selective serotonin reuptake inhibitor augments harmaline-induced tremor in rats","volume":"153","author":"Arshaduddin","year":"2004","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.parkreldis.2012.04.024_bib7","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1212\/01.WNL.0000031424.51127.2B","article-title":"Tremor in Parkinson\u2019s disease and serotonergic dysfunction. An 11C-WAY 100635 PET study","volume":"60","author":"Doder","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2012.04.024_bib8","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1097\/00004691-200411000-00009","article-title":"Routine neurophysiological tremor analysis as a diagnostic tool for essential tremor: a prospective study","volume":"21","author":"Gironell","year":"2004","journal-title":"J\u00a0Clin Neurophysiol"},{"issue":"Suppl. 3","key":"10.1016\/j.parkreldis.2012.04.024_bib9","first-page":"2","article-title":"Consensus statement of the movement disorder Society on tremor","volume":"13","author":"Deuschl","year":"1998","journal-title":"Mov Disord"},{"key":"10.1016\/j.parkreldis.2012.04.024_bib10","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.parkreldis.2010.04.001","article-title":"The glass scale: a simple tool to determine severity in essential tremor","volume":"16","author":"Gironell","year":"2010","journal-title":"Parkinsonism Rel Disord"},{"key":"10.1016\/j.parkreldis.2012.04.024_bib11","series-title":"Parkinson's disease and movement disorders","first-page":"225","article-title":"Clinical rating scale for tremor","author":"Fahn","year":"1988"},{"key":"10.1016\/j.parkreldis.2012.04.024_bib12","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/0020-708X(84)90215-1","article-title":"Synthesis of ethyl 8-fluoro-5,6-dihydro-5-[11C]methyl-6-oxo-4H-imidazo [1,5-a] [1,4]benzodiazepine-3-carboxylate (RO 15.1788-11C): a specific radioligand for the in\u00a0vivo study of central benzodiazepine receptors by positron emission tomography","volume":"35","author":"Maziere","year":"1984","journal-title":"Int J Appl Radiat Isot"},{"key":"10.1016\/j.parkreldis.2012.04.024_bib13","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/S0969-8051(02)00316-5","article-title":"In\u00a0vitro and in\u00a0vivo characterisation of [11C]-DASB: a probe for in\u00a0vivo measurements of the serotonin transporter by positron emission tomography","volume":"29","author":"Wilson","year":"2002","journal-title":"Nucl Med Biol"},{"key":"10.1016\/j.parkreldis.2012.04.024_bib14","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/S1053-8119(03)00072-7","article-title":"Influence of the normalization template on the outcome of statistical parametric mapping of PET scans","volume":"19","author":"Gispert","year":"2003","journal-title":"Neuroimage"},{"key":"10.1016\/j.parkreldis.2012.04.024_bib15","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1097\/01.WCB.0000085441.37552.CA","article-title":"Linearized reference tissue parametric imaging methods: application to [11C]DASB positron emission tomography studies of the serotonin transporter in human brain","volume":"23","author":"Ichise","year":"2003","journal-title":"J\u00a0Cereb Blood Flow Metab"},{"key":"10.1016\/j.parkreldis.2012.04.024_bib16","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1097\/00004647-200212000-00004","article-title":"Noise reduction in the simplified reference tissue model for neuroreceptor functional imaging","volume":"22","author":"Wu","year":"2002","journal-title":"J\u00a0Cereb Blood Flow Metab"},{"key":"10.1016\/j.parkreldis.2012.04.024_bib17","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1176\/appi.ajp.158.11.1843","article-title":"Occupancy of serotonin transporters by paroxetine and citalopram during treatment of depression: a [(11)C]DASB PET imaging study","volume":"158","author":"Meyer","year":"2001","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.parkreldis.2012.04.024_bib18","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1007\/s00213-007-0806-z","article-title":"Serotonin transporter occupancy of high-dose selective serotonin reuptake inhibitors during major depressive disorder measured with [11C]DASB positron emission tomography","volume":"193","author":"Voineskos","year":"2007","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.parkreldis.2012.04.024_bib19","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.neuroimage.2008.12.005","article-title":"[18F]flumazenil binding to central benzodiazepine receptor studies by PET\u2013quantitative analysis and comparisons with [11C]flumazenil","volume":"45","author":"Odano","year":"2009","journal-title":"Neuroimage"},{"key":"10.1016\/j.parkreldis.2012.04.024_bib20","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1001\/archneur.56.4.475","article-title":"A\u00a0double-blind placebo-controlled trial of gabapentin and propranolol in patients with essential tremor","volume":"56","author":"Gironell","year":"1999","journal-title":"Arch Neurol"},{"key":"10.1016\/j.parkreldis.2012.04.024_bib21","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1007\/BF01273153","article-title":"Change in the concentrations of amino acids in CSF and serum of patients with essential tremor","volume":"103","author":"Mally","year":"1996","journal-title":"J\u00a0Neural Transm"},{"key":"10.1016\/j.parkreldis.2012.04.024_bib22","doi-asserted-by":"crossref","first-page":"3297","DOI":"10.1093\/brain\/awm266","article-title":"Neuropathological changes in essential tremor: 33 cases compared with 21 controls","volume":"130","author":"Louis","year":"2007","journal-title":"Brain"},{"key":"10.1016\/j.parkreldis.2012.04.024_bib23","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1093\/brain\/awr301","article-title":"Defective dentate nucleus GABA receptors in essential tremor","volume":"135","author":"Paris-Robidas","year":"2012","journal-title":"Brain"},{"key":"10.1016\/j.parkreldis.2012.04.024_bib24","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1002\/1531-8249(199908)46:2<249::AID-ANA15>3.0.CO;2-C","article-title":"Tremor arrest with thalamic microinjections of muscimol in patients with essential tremor","volume":"46","author":"Pahapill","year":"1999","journal-title":"Ann Neurol"},{"key":"10.1016\/j.parkreldis.2012.04.024_bib25","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1001\/archneur.59.3.413","article-title":"Transcranial magnetic stimulation of the cerebellum in essential tremor: a controlled study","volume":"59","author":"Gironell","year":"2002","journal-title":"Arch Neurol"},{"key":"10.1016\/j.parkreldis.2012.04.024_bib26","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1016\/0140-6736(90)92489-5","article-title":"Preliminary report: activation of the cerebellum in essential tremor","volume":"336","author":"Colebatch","year":"1990","journal-title":"Lancet"},{"key":"10.1016\/j.parkreldis.2012.04.024_bib27","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0304-3940(02)00966-7","article-title":"Metabolic abnormality in the cerebellum in patients with essential tremor: a proton magnetic resonance spectroscopic imaging study","volume":"333","author":"Louis","year":"2002","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.parkreldis.2012.04.024_bib28","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/ana.410410108","article-title":"Activation mapping in essential tremor with functional magnetic resonance imaging","volume":"41","author":"Bucher","year":"1997","journal-title":"Ann Neurol"},{"key":"10.1016\/j.parkreldis.2012.04.024_bib29","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1002\/mds.870130315","article-title":"Double-blind controlled trial of gabapentin in essential tremor","volume":"13","author":"Pahwa","year":"1998","journal-title":"Mov Disord"},{"key":"10.1016\/j.parkreldis.2012.04.024_bib30","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1001\/archneur.1987.00520210007009","article-title":"Pharmacologic probe with progabide of GABA mechanisms in essential tremor","volume":"44","author":"Koller","year":"1987","journal-title":"Arch Neurol"},{"key":"10.1016\/j.parkreldis.2012.04.024_bib31","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1111\/j.1600-0404.1983.tb04833.x","article-title":"The effect of the GABA-agonist, progabide on benign essential tremor","volume":"768","author":"Mondrup","year":"1983","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.parkreldis.2012.04.024_bib32","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1002\/mds.22094","article-title":"Tiagabine for essential tremor: an open-label trial","volume":"23","author":"Gironell","year":"2008","journal-title":"Mov Disord"}],"container-title":["Parkinsonism &amp; Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802012001563?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802012001563?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,23]],"date-time":"2018-11-23T12:20:08Z","timestamp":1542975608000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1353802012001563"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8]]},"references-count":32,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2012,8]]}},"alternative-id":["S1353802012001563"],"URL":"https:\/\/doi.org\/10.1016\/j.parkreldis.2012.04.024","relation":{},"ISSN":["1353-8020"],"issn-type":[{"value":"1353-8020","type":"print"}],"subject":[],"published":{"date-parts":[[2012,8]]}}}